Zynx Update March 2013

 

Updated Content


Order Set Updates (Immediate Attention Required)
For instructions, click here.

Withdrawn Evidence Links

  • Abdominal Aortic Aneurysm Repair

    • Hospital Preoperative

      • For patients undergoing elective AAA repair, the evidence for preoperative systemic corticosteroid administration is inconclusive

    • Postoperative

      • For patients undergoing elective AAA repair, the evidence for early enteral feeding postoperatively is inconclusive

  • Acute Myocardial Infarction/STEMI

    • All Venues (except IV Thrombolysis)

      • Diuretics: Loop

    • Venues: Admission to ICU, Admission to Telemetry, Modular Order Set (ICU and Telemetry)

      • Avoid Valsalva maneuver
      • Cardiac Glycosides
      • Cardiac monitor
      • Complete blood cell count with automated white blood cell differential
      • Consider early transfer for eligible patients
      • For patients who have acute MI/STEMI and heart failure, DVT prophylaxis should be administered, with an LMWH as the preferred agent
      • Sodium Chloride 0.9% IV
      • VTE Prophylaxis: Low-Dose Unfractionated Heparin
      • VTE Prophylaxis: Low-Molecular-Weight Heparins

    • Venues: Admission to ICU, Emergency Department Treatment, Modular Order Set (ICU and Telemetry)

      • Consider intra-arterial pressure monitoring for a specific subset of patients
      • Consider pulmonary artery catheter monitoring for patients who develop certain complications

    • Emergency Department Treatment

      • Avoid Valsalva maneuver
      • Cardiac Glycosides
      • Cardiac monitor
      • Complete blood cell count with automated white blood cell differential
      • Sodium Chloride 0.9% IV

    • IV Thrombolysis

      • Cardiac monitor
      • Complete blood cell count with automated white blood cell differential

  • Biliary Atresia – Neonatal

    • Venues: Admission to Level III NICU, Starter Order Set (based on Admission to Level III NICU)

      • Phenobarbital level

  • Critical Care Management – Adult

    • Short Set > Venue > Admission to ICU

      • 12-lead ECG
      • Cardiac monitor
      • For patients who have been receiving a propofol infusion for 2 days, monitor triglyceride concentrations
      • Triglycerides

  • Critical Care Management – Pediatric

    • Short Set > Venue > Admission to PICU

      • Assess neurologic status
      • Cardiac monitor
      • For patients with delirium, consider the use of a neuroleptic agent

  • Diabetes/Hyperglycemia

    • Venues: Short Set > Management > Diabetes/Hyperglycemia, Starter Order Set (based on Short Set > Management > Diabetes/Hyperglycemia)

      • For hospitalized patients with diabetes mellitus or nondiabetic hyperglycemia, avoid initiation of thiazolidinediones for inpatient glycemic control; however, evidence for its continuation or discontinuation in the inpatient setting remains unclear and requires evaluation of the specific clinical situation
      • For hospitalized patients with diabetes mellitus or nondiabetic hyperglycemia, avoid the routine use of metFORMIN
      • For hospitalized patients with diabetes mellitus or nondiabetic hyperglycemia, the evidence for the use of sulfonylureas is inconclusive
      • For selected hospitalized patients with diabetes mellitus, consider allowing insulin self-management as an adjunct to standard diabetes care
      • Insulins: Continuous Infusions
      • Sulfonylureas
      • The use of thiazolidinediones in patients with CHF or other heart disease should be undertaken with caution

  • DKA/HHS – Pediatric

    • All Venues (except Discharge)

      • 12-lead ECG
      • Admit patients at risk for cerebral edema or with severe DKA to the ICU
      • Assess neurologic status
      • Blood gas, arterial
      • Blood urea nitrogen
      • Calcium level, serum, total
      • Complete blood cell count with automated white blood cell differential
      • Creatinine (Cr), serum
      • Electrolyte panel
      • Glucose, serum, random
      • Hematocrit (Hct)
      • Ketones, urine
      • Osmolality, serum
      • Phosphate Supplements
      • Phosphorus level, serum
      • Potassium level, serum
      • Urinalysis (UA) with microscopy

    • Venues: Admission to Pediatric Med/Surg, Admission to PICU, Starter Order Set (based on Admission to PICU)

      • Consider phosphate replacement for serum phosphate less than 1.0 mg/dL or for hypophosphatemia signs (eg, anemia, cardiac dysfunction, hypoxia)
      • Glucose, blood, point-of-care measurement fingerstick
      • Measure intake and output
      • Perform hourly monitoring of vital signs

    • Venues: Admission to PICU, Emergency Department Treatment, Starter Order Set (based on Admission to PICU)

      • Alkalinizing Agents
      • Avoid the routine use of IV bicarbonate if pH is 7.0 or greater
      • Consider adding bicarbonate to IV fluid therapy if pH is less than 6.9 or in the presence of life-threatening hyperkalemia
      • Consider addition of potassium to IV fluids, based on the serum potassium levels and generally at a rate less than or equal to 0.5 mmol/kg per hour

    • Admission to Pediatric Med/Surg

      • Blood gas, venous
      • Consider oral rehydration for patients who are showing significant clinical improvement in response to treatment

    • Admission to PICU

      • Blood gas, venous
      • Perform hourly (or more frequent) monitoring of input and output
      • Perform hourly (or more frequent) neurologic checks
      • Perform hourly glucose monitoring

    • Emergency Department Treatment

      • Blood gas, venous
      • Consider oral rehydration for patients who are showing significant clinical improvement in response to treatment
      • Glucose, blood, point-of-care measurement
      • Urine dipstick, point-of-care measurement
      • Vital signs

    • Starter Order Set (based on Admission to PICU)

      • Perform hourly (or more frequent) monitoring of input and output
      • Perform hourly (or more frequent) neurologic checks
      • Perform hourly glucose monitoring
      • Vital signs

  • Heart Failure

    • All Venues (except Discharge)

      • Measure height

  • Lumbar Laminectomy

    • All Venues

      • Education, activity

    • Hospital Preoperative

      • Consider perioperative patient education

  • Lung Resection

    • Postoperative

      • For high-risk patients, the evidence for an inhaled short-acting beta-2 agonist postoperatively is inconclusive

  • Prematurity – Neonatal
    • All Venues

      • Apnea monitor

    • Short Set > Venue > Discharge from NICU – Prematurity

      • Cardiac monitor

  • Preterm Labor

    • All Venues (except Admission to Antepartum and Discharge)

      • Culture, urine

  • Syncope

    • Emergency Department > Symptoms > Syncope

      • Perform a history and physical examination to aid with diagnosis

  • Transplant – Liver

    • Venues: Hospital Preoperative, Postoperative

      • Diuretics: Osmotic
      • Intracranial pressure monitor

    • Starter Order Set (based on Hospital Preoperative)

      • Diuretics: Osmotic

  • Urinary Tract Infection – Adult

    • All Venues (except Discharge)

      • Culture, blood

Split Evidence Links

  • There are no split evidence links.


Other Updates
New Modules

  • Antimicrobials – Empiric, Adult

New Evidence Topics

  • Acute Myocardial Infarction/STEMI: Hypothermia
  • Appendicitis/Appendectomy – Adult: Surgery Timing
  • Appendicitis/Appendectomy – Pediatric: Early Discharge
  • Appendicitis/Appendectomy – Pediatric: Protocol – Diagnostic
  • Brain Injury: Glucose Management
  • Cancer – Lung, Small Cell: Stage Documentation
  • Colectomy: Blood Transfusion
  • Colectomy: C-Reactive Protein
  • Colectomy: Infection Control
  • Colectomy: MRI – Pelvis
  • Critical Care Management – Adult: Analgesics – Adjuvant
  • Critical Care Management – Adult: Antipsychotic Agents
  • Critical Care Management – Adult: Early Mobilization
  • Critical Care Management – Adult: Protocol – Glucose Management
  • Critical Care Management – Neonatal: Telemedicine
  • Depression: Consult – Case Management
  • Dyslipidemia: Hormone Replacement Therapy
  • Gastrointestinal Bleeding – Lower: CT – Enterography
  • Gastrointestinal Bleeding – Upper: Condition Volume
  • Gastrointestinal Bleeding – Upper: Specialty Provider
  • Hepatectomy: MRI – Abdomen
  • Hepatectomy: MRI – Pelvis
  • Hysterectomy – Abdominal: Protocol – Fast-tracking
  • Lung Resection: Care Setting
  • Lung Resection: Protocol – Fast-tracking
  • Lymphoma – B-Cell, Diffuse Large: Stage Documentation
  • Lymphoma – B-Cell, Follicular: Stage Documentation
  • Lymphoma – Hodgkin: Stage Documentation
  • Necrotizing Enterocolitis – Neonatal: Care Setting
  • Newborn Management: Clothing Choice
  • Perioperative Care: Antipsychotic Agents
  • Pneumonia – CAP, Adult: Noninvasive Ventilation
  • Pneumonia – Nosocomial: Polymyxin Derivatives
  • Prematurity – Neonatal: Organizational Policy
  • Prematurity – Neonatal: Protocol – Retinopathy of Prematurity Screening
  • Retinopathy of Prematurity – Neonatal: Follow-up
  • Retinopathy of Prematurity – Neonatal: Parent/Caregiver Education
  • Retinopathy of Prematurity – Neonatal: Retinal Examination
  • Spontaneous Abortion: Cervical Dilator
  • Spontaneous Abortion: Nitrates
  • Spontaneous Abortion: Progestins
  • Transplant – Heart: Continuous Cardiac Monitoring
  • Transplant – Heart: ECG
  • Transplant – Heart: Postoperative Monitoring
  • Transplant – Heart: Vasoactive Agents
  • Unstable Angina/NSTEMI: Activity
  • Urinary Tract Infection – Adult: History and Physical Examination
  • Venous Thromboembolism – Prophylaxis: Reminder System

 

Back to the Top

> E-mail this page

 


FDA Drug Safety Alerts
 

Click here for FDA Safety Alerts relevant to Zynx evidence.
_
Zynx Update does not address the addition, deletion, or modification of clinical rules, nor does it address the addition of items or the deletion of non–evidence-based items from order sets or plans of care. Zynx Update is intended for use by quality improvement personnel who can review the information provided to help decide if modifications should be made to existing order sets, plans of care, and rules, based on changes to the evidence.